Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cannabis oil + cannabis vape
- Development stage
- Unknown
- Lead developer
- Panaxia Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral, Inhalation
01
Overview
The cannabis oil and cannabis vape product line refers to a suite of medical cannabis-based botanical drugs developed by Segal Pharma Group in partnership with Panaxia Pharmaceutical Industries. These products are standardized extracts containing specific ratios of cannabinoids, primarily delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC acts as a partial agonist at the cannabinoid receptors CB1 and CB2, providing analgesic, anti-emetic, and muscle relaxant effects, while CBD interacts with various targets including TRPV1 and 5-HT1A receptors to provide anti-inflammatory and anti-convulsant properties. The products are available in multiple delivery forms, including oils for oral administration and cartridges for inhalation via vaporization. They are approved in Israel for a variety of medical indications, including chronic pain, cancer-related symptoms, treatment-resistant epilepsy, and palliative care.
- Brand names
- Panaxia
- Other names
- cannabis-based medicine
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on cannabis oil + cannabis vape.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cannabis oil + cannabis vape.